This annotated bibliography, which covers publications appearing from April 2014 to January 2015, is the second in a series of working papers delving into the policy and practical issues defining the path to universal health coverage. This series aims to inform discussions of UHC and monitor the progress of the global health debate over the next few years. Given the large and growing literature on universal health coverage, this cannot be comprehensive. Instead, it is intended to complement the first bibliography and to continue to serve as a guide to the subject as it evolves.
This project is supported by unrestricted educational grants from the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Merck KGaA, Darmstadt, Germany, Novartis, and the Pharmaceutical Research and Manufacturers of America (PhRMA).